Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ... [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
Glucagon Sales: $26.7 million, a 9% decline from the previous year. Vaccine Sales: $40.4 million through Amphastar, $6.4 million by Eli Lilly. Epinephrine Sales: $21.3 million, a 6% increase. Phytonadione Sales: $11.7 million, a 57% increase. Gross Margin: Declined to 53% from 60% in the prior year. Net Income: $40.4 million, an 18% decrease from the previous year. Adjusted Net Income: $49.6 million, compared to $61.9 million in the previous year. Cash Flow from Operations: Approximately $60 million. Share Repurchase: $35 million used to repurchase 797,000 shares. New Buyback Program: Authorized an additional $50 million. Warning! GuruFocus has detected 3 Warning Signs with AMPH. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Amphastar Pharmaceuticals Inc ( NASDAQ:AMPH ) reported a 6% increase in net revenues year over year, reaching $191.2 million, demonstrating resilience
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare ConferenceAccesswire
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $55.00 price target on the stock.MarketBeat
AMPH
Earnings
- 11/6/24 - Beat
AMPH
Sec Filings
- 12/16/24 - Form 4
- 12/11/24 - Form 4
- 12/9/24 - Form 144
- AMPH's page on the SEC website